Compare TRMK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRMK | LMAT |
|---|---|---|
| Founded | 1889 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 1987 | 2006 |
| Metric | TRMK | LMAT |
|---|---|---|
| Price | $40.63 | $83.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $42.67 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 276.0K | 188.5K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.36% | 0.95% |
| EPS Growth | 10.82 | ★ 27.40 |
| EPS | ★ 3.66 | 2.32 |
| Revenue | ★ $773,338,000.00 | $240,866,000.00 |
| Revenue This Year | $58.57 | $15.17 |
| Revenue Next Year | $4.65 | $9.07 |
| P/E Ratio | ★ $11.10 | $36.21 |
| Revenue Growth | ★ 55.58 | 13.07 |
| 52 Week Low | $29.77 | $71.42 |
| 52 Week High | $41.34 | $105.55 |
| Indicator | TRMK | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 42.77 |
| Support Level | $37.37 | $82.31 |
| Resistance Level | $41.22 | $84.86 |
| Average True Range (ATR) | 1.13 | 2.72 |
| MACD | 0.22 | -0.01 |
| Stochastic Oscillator | 85.65 | 23.64 |
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.